Metraipolis › archive › dc_84b6e2cc2c23
Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction — Europe PMC PMID:41958458
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41958458
- DOI
- 10.3389/fcvm.2026.1753965
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T22:20:45.818Z
- SHA-256 of the archived text
6de4a9ee47205e43afaafc85cb3c2d6f181898bdba9b56c36f900e3cd11ffcf7- Stable URL of this page
https://metraipolis.com/documento/dc_84b6e2cc2c23
How to cite
Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction — Europe PMC PMID:41958458 — Europe PMC (en), https://europepmc.org/article/MED/41958458 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_84b6e2cc2c23 (Metraipolis archive dc_84b6e2cc2c23, sha256 6de4a9ee47205e43afaafc85cb3c2d6f181898bdba9b56c36f900e3cd11ffcf7)
BibTeX
@misc{dc84b6e2cc2c23,
title = {Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction — Europe PMC PMID:41958458},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41958458},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_84b6e2cc2c23; sha256 6de4a9ee47205e43afaafc85cb3c2d6f181898bdba9b56c36f900e3cd11ffcf7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41958458. Agents can read the archived copy with the MCP tool read_document.